Day: February 19, 2025

KISSIMMEE, Fla., Feb. 19, 2025 (GLOBE NEWSWIRE) — ECD Auto Design, the world-renowned leader in custom luxury vehicle restoration, is proud to announce the expansion of its Exclusive Inventory program to meet increasing client demand for higher-spec vehicles with no wait time. This initiative introduces meticulously crafted Land Rover SUVs, offering a range of premium appointments for those who seek unparalleled craftsmanship and performance that are readily available. Elevating Inventory with Exclusive Lineups Recognizing the demand for meticulously crafted, ready-to-drive luxury classic vehicles, ECD has elevated its Exclusive Inventory strategy with an annual collection of approximately 20 extremely unique well-appointed custom vehicles. Designed by ECD’s founders, these high-performance models showcase bold colors, leading...

ALK (ALKB:DC / OMX: ALK B / AKBLF): The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 13 March 2025 at 4:00 PM (CET) at ALK-Abelló A/S, Bøge Allé 1, 2970 Hørsholm, Denmark. The agenda of the meeting including the complete proposals from the Board of Directors to the AGM is attached. ALK-Abelló A/S For further information please contact: Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525 Media: Maiken Riise Andersen, tel. +45 5054 1434 About ALKALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at...

MCLEAN, Va., Feb. 19, 2025 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU), a publicly traded leader in next-generation cybersecurity solutions, is excited to announce an exclusive partnership with iQSTEL Inc. (OTCQX: IQST), a multinational innovator in telecommunications, fintech, electric vehicles (EV), and AI-driven solutions. This strategic collaboration grants Cycurion exclusive rights to deliver its top-tier cybersecurity products to the U.S. telecommunications industry through iQSTEL’s vast network while also expanding its reach into other high-growth sectors internationally. With iQSTEL’s extensive global presence—spanning 17 time zones and seven offices worldwide—this partnership will drive the adoption of advanced cybersecurity solutions across Europe, Latin America, the Middle East, and the United States. By integrating...

NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) — Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) is pleased to announce that J. Allen Gray has been promoted to Head of Institutional Business. In this role, he will oversee Silvercrest’s institutional business, as well as consultant and client relations. Since joining Silvercrest in 2008, Mr. Gray has played a pivotal role in the success of the firm’s institutional equity business. He is a Silvercrest Partner and Managing Director, and a member of the company’s Executive Committee. Richard Hough, Chairman and Chief Executive Officer of Silvercrest, remarked, “We are immensely proud of Allen Gray’s success and of our talented equity management teams, with whom he has worked so closely for over 15 years. We are thrilled to have Allen leading our institutional business efforts.” About...

Building on proven targeting of the FHAB domain, Sonnet’s ADC platform offers flexible payload capacity and controllable drug-antibody ratios (DAR) An epidermal growth factor receptor 2 (HER2) ADC construct designated – SON-5010 showed similar activities as compared with Kadcyla® and also trastuzumab-MMAE, in a preclinical study Company’s ADC Platform offers the potential for novel ADCs with homogeneous structural integrity, tumor targeting domain, interchangeability of toxin payloads and flexible conjugation site usage Management releases “What This Means” segment discussing its ADC platform; Access here PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced its plans...

DUBLIN and BRIDGEWATER, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its fourth quarter and full year 2024 results followed by Q&A on Wednesday, March 12th, 2025, at 8:00 a.m. ET. The conference call with management will follow the release of the Company’s fourth quarter 2024 financial results in the pre-market hours on March 12th.   Conference Call and Webcast Information:  Access to the live call: Go to the investor relations section of the Company’s website at www.amarincorp.comDial in within the United States: 888-506-0062International dial in: 973-528-0011Access Code: 575561 Access to replay: Dial in within the United States: 877-481-4010 International...